Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$2.23 - $4.38 $178,839 - $351,262
80,197 New
80,197 $186,000
Q3 2022

Nov 04, 2022

BUY
$10.32 - $17.28 $275,213 - $460,823
26,668 New
26,668 $287,000
Q2 2022

Jul 29, 2022

SELL
$6.78 - $12.28 $240,012 - $434,712
-35,400 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$7.65 - $15.29 $270,810 - $541,266
35,400 New
35,400 $321,000
Q4 2021

Jan 21, 2022

SELL
$13.13 - $24.52 $100,326 - $187,357
-7,641 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$21.01 - $27.64 $133,056 - $175,044
6,333 Added 484.17%
7,641 $196,000
Q2 2021

Aug 04, 2021

SELL
$23.49 - $35.8 $1.33 Million - $2.02 Million
-56,521 Reduced 97.74%
1,308 $34,000
Q1 2021

May 10, 2021

SELL
$25.79 - $39.02 $302,877 - $458,250
-11,744 Reduced 16.88%
57,829 $2.04 Million
Q4 2020

Feb 08, 2021

BUY
$25.24 - $43.45 $1.04 Million - $1.79 Million
41,136 Added 144.66%
69,573 $1.76 Million
Q3 2020

Nov 09, 2020

BUY
$32.38 - $44.96 $789,618 - $1.1 Million
24,386 Added 601.97%
28,437 $1.07 Million
Q2 2020

Aug 05, 2020

SELL
$18.39 - $54.04 $143,589 - $421,944
-7,808 Reduced 65.84%
4,051 $172,000
Q1 2020

May 06, 2020

SELL
$18.22 - $28.25 $878,367 - $1.36 Million
-48,209 Reduced 80.26%
11,859 $230,000
Q4 2019

Jan 29, 2020

BUY
$24.82 - $31.4 $583,567 - $738,276
23,512 Added 64.32%
60,068 $1.56 Million
Q3 2019

Nov 01, 2019

BUY
$26.11 - $32.99 $954,477 - $1.21 Million
36,556 New
36,556 $996,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.